A recent study conducted at New York stated that women who are taking common class of drugs such as bisphosphonates for osteoporosis are significantly at reduced risk of breast cancer than women who are not using the bone-strengthening pills.
Now you can find Fosamax in the form of alendronate. Some other most commonly used medicines from the same class include Actonel and Roche's Boniva. Women who were taking bisphosphonates are one-third less likely to develop breast cancer than women who do not take them.
Drugs, such as Fosamax and Boniva, are some of the most popular drugs for women to help prevent bone loss, but a government health study found those taking the drugs for osteoporosis were also 32 percent less likely to be diagnosed with breast cancer.
Researchers said that the medications used for osteoporosis may make it more difficult for
tumors to develop.
Saturday, December 12, 2009
Subscribe to:
Post Comments (Atom)
Hi,
ReplyDeleteI am The assistant editor with disease.com. I really liked your site and I am interested in building a relationship with your site. We want to spread public awareness. I hope you can help me out. Your site is a very useful resource.
Please email me back with your URL in subject line to take a step ahead an to avoid spam.
Thank you,
Lisa Hope
lisa.disease.com@gmail.com